BMAL1 is primarily found in large complexes of clock proteins within the nucleus [1] , but little was known about its status in the cytosol. Using mass spectrometry of cytosolic BMAL1 complexes from mouse embryonic fibroblasts (MEFs), the authors found a surprising enrichment of translation factors, including eukaryotic translation initiation and elongation factors (eIF and eEFs) and polyadenylate binding protein 1 (PABP1), which are generally regarded as components of the cap-binding complex (CBC). Complexes of BMAL1 with these factors bound to immobilized 7-methyl guanosine (m 7 -GTP), which mimics the 'cap' at the 5 0 end of most mRNAs. Correspondingly, Bmal1 -/-MEFs had a striking decrease in steady-state levels of de novo protein synthesis, and the addition of BMAL1 stimulated cap-dependent translation. Given that cap-binding complexes containing BMAL1 were detected in cytosolic fractions of mouse liver and brain, there is some evidence that translational regulation by BMAL1 may occur widely across tissues. Clock-regulated processes, by definition, have peak activity at a specific time of day. Sahin and colleagues found that de novo protein synthesis was increased in the liver in a Bmal1-dependent manner at the end of the dark cycle (Zeitgeber time 0, ZT0) when cytosolic BMAL1 was also found to preferentially associate with cap-binding complexes. What factors determine the temporal basis of translation regulation by BMAL1? Translation regulation integrates responses from many signaling pathways, including the mechanistic Target of Rapamycin (mTOR) pathway. The authors identified a conserved phosphorylation motif within the BMAL1 N terminus that is targeted by the mTOR-dependent kinase, S6K1. Phosphorylation of Serine 42 (S42) was required for association with translation factors and stimulation of cap-dependent translation. Activation of the mTOR pathway oscillates on a circadian basis, as demonstrated by cycling levels of activated S6K1 that peak during the evening in mouse liver [8] . Here, Sahin and colleagues show that phosphorylation of BMAL1 S42 also occurs on a circadian basis in liver and MEFs, and can be upregulated by deletion of the mTOR suppressor Tsc1, thereby linking translation regulation by BMAL1 to mTOR.
Sahin and colleagues investigated the degree of overlap between the two activities of BMAL1, asking whether its nuclear and cytosolic roles were independent, and whether the two roles represented distinct pools of BMAL1 protein. They showed that the ability of BMAL1 to regulate translation is independent of its transcriptional role, as a transcriptionally dead mutant (lacking the bHLH DNA binding domain) could still enhance capdependent translation. Moreover, while phosphorylation at S42 is necessary to prime BMAL1 for association with the translational machinery, the S42G mutant does not affect the transcriptional activity of BMAL1 or timing of the circadian clock itself, suggesting that the transcriptional and translational roles of BMAL1 are completely separable.
Interesting links between the molecular clock and translation regulation remain unexplored. Bmal1-dependent stimulation of protein synthesis appears to be dependent on the rhythmic cycling of Bmal1 mRNA, because rhythms of translation regulation were blunted when BMAL1 was constitutively overexpressed, whereas the transcription-based clock functioned normally. Notably, some apparent rhythms in translation appeared to persist in Bmal1 -/-MEFs, in which the molecular clock is completely disrupted [9] . This demonstrates that while rhythms of protein synthesis are clearly dependent on cycling BMAL1 levels, they also receive input from other stimuli that occur on a daily basis even in the absence of a molecular clock. The identification of these daily stimuli (e.g., feeding, sleep/wake cycle and/or other daily behaviors) and how they interface with translation regulation remain to be determined.
Bmal1 -/-mice also exhibit severe co-morbid phenotypes such as premature aging with decreased activity and body weight [9] . Some of these phenotypes are rescued by tissue-specific restoration of Bmal1 expression, while others are not [10] . This new insight into the moonlighting role of BMAL1 in translational regulation could help to explain the particularly strong phenotypes seen with deletion of Bmal1, which may perturb cellular function beyond disruption of the transcription-based circadian clock. Future studies investigating the effects of circadian disruption or metabolic perturbation on the translational activity of BMAL1 may provide insight into how circadian translational interference promotes disease.
